Targeted drug administration, also known as smart drug delivery, is a technique for administering medications to a patient in such a way that the medication is more concentrated in some areas of the body than others. This method of delivery is mostly based on nanomedicine, which aims to use medication administration via nanoparticles to counter the drawbacks of traditional drug delivery. These drug-loaded nanoparticles would be directed to specific areas of the body that only contain sick tissue, avoiding contact with healthy tissue. A targeted medicine delivery system aims to extend, localise, target, and engage with the sick tissue in a safe manner. While the targeted release system delivers the medicine in a dose form, the traditional drug delivery method involves the drug being absorbed through a biological membrane. The patient will need to take fewer doses more frequently, the medicine will have a more consistent impact, there will be fewer adverse effects, and there will be less volatility in the drug levels in the blood. The system's drawbacks include a hefty price tag that makes productivity more challenging and a limited capacity to change doses. To maximise the effectiveness of regeneration methods, targeted medication delivery systems have been created. The system is based on a technique that delivers a specific quantity of a therapeutic drug to a particular sick location over an extended period of time. This aids in maintaining the necessary blood serum and tissues drug concentrations in the body, preventing any drug-induced harm to healthy tissue. The medication delivery system is extremely interconnected, so it takes experts from several fields—such as chemists, biologists, and engineers—working together to make it as efficient as possible.
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : A NAMs-compatible mechanopharmacological model of drug penetration in the urinary bladder
Kunal Sharma, Swisss Federal Institute of Technology Lausanne, Switzerland
Title : Application of quality by design for pulmonary liposomes: Preliminary study to nano in-microparticle
Lucas Amaral Machado, University of Sao Paulo State – UNESP, Brazil
Title : Integrated Raman, SERS and computational approaches for the study of bioactive molecules in pharmaceutical chemistry
Maria Cristina Gamberini, University of Modena and Reggio Emilia, Italy
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada